Company profile: MC3 Cardiopulmonary
1.1 - Company Overview
Company description
- Provider of cardiopulmonary devices, including the Nautilus Smart ECMO module for extracorporeal life support with blood oxygenation, CO2 removal, and temperature regulation via integrated sensors and touch-screen monitoring; the Crescent Jugular Dual Lumen Catheter for V-V ECMO in acute respiratory failure; and the Soft-Flow Arterial Cannula for gentle aortic perfusion, distributed globally by Medtronic.
Products and services
- Crescent Jugular Dual Lumen Catheter: Jugular-access catheter for veno-venous ECMO, delivering venous drainage and reinfusion via the jugular vein for patients with acute respiratory failure
- Nautilus Smart ECMO: Sensor-integrated ECMO module that oxygenates blood, removes carbon dioxide, and regulates blood temperature, with a touch screen enabling real-time monitoring during extracorporeal life support
- Soft-Flow Arterial Cannula: Diffusion-tip arterial cannula enabling gentle perfusion of the aorta during cardiopulmonary bypass procedures, globally distributed by Medtronic
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MC3 Cardiopulmonary
Foldax
HQ: United States
Website
- Description: Provider of synthetic heart valve solutions delivering non-thrombogenic aortic and mitral valves at lower cost, including TRIA surgical and TAVR valves with computer-designed frames and leaflets to match natural function; LifePolymer non-animal polymer offering biostability, biocompatibility and resistance to calcification; automated robotic manufacturing, FEA design, and polymer applications in medical and industrial devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Foldax company profile →
SonoVol
HQ: United States
Website
- Description: Provider of a fully-automated benchtop ultrasound platform designed to lower the barrier of entry for biologists performing preclinical screening or acquiring longitudinal in vivo data across pharmaceutical, biotech, government, and academic markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SonoVol company profile →
IDEV
HQ: United States
Website
- Description: Provider of endovascular and interventional medical devices, marketing SUPERA, a novel self-expanding nitinol stent with a patented interwoven design that enhances flexibility, radial strength, and resistance to kinking and crushing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEV company profile →
LeMaitre
HQ: United States
Website
- Description: Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LeMaitre company profile →
MGC Diagnostics
HQ: United States
Website
- Description: Provider of non-invasive diagnostic systems for detecting and managing cardiorespiratory disease, delivered by a global medical technology company dedicated to cardiorespiratory health solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MGC Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MC3 Cardiopulmonary
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MC3 Cardiopulmonary
2.2 - Growth funds investing in similar companies to MC3 Cardiopulmonary
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MC3 Cardiopulmonary
4.2 - Public trading comparable groups for MC3 Cardiopulmonary
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →